Shaun Foy
Co-FounderMr. Shaun Foy, CFA, is Co-Founder of CRISPR Therapeutics, Inc. Mr. Foy is Co-Founder of CRISPR Therapeutics AG and served as its Chief Financial Officer. He is Director of Accel-Rx. He served as Board Advisor at Amplitude Ventures Inc. He was Partner of Phase4 Partners Limited. He joined the Healthcare team in 1998 and has focused on investment activities since 1999. Whilst in the Healthcare team, Mr. Foy was involved in corporate finance transactions ranging from advising on public and private financings to mergers and acquisitions. He has been actively involved in investments. Mr. Foy is an Observer on the Boards of Nabriva and DeveloGen. He is the Member of Board of Directors at Accel-Rx. He served as a Director of CRISPR Therapeutics AG. He holds the C.F.A. designation and is a member of the UK Society for Investment Professionals. Mr. Foy is a life science entrepreneur with several years’ experience investing, advising and building emerging healthcare companies. He studied at the University of British Columbia where he obtained a M.Sc. and B.Sc. with honors in Cell Biology and Immunology.
Positions
- Company NameCRISPR Therapeutics AGStock CodeCRSPPositionCo-FounderColleagues
- SKSamarth KulkarniCEO & Chairman
- JRJames R. KasingerGeneral Counsel & Secretary
- RYRaju Yashaswi PrasadExecutive Officer
- NPNaimish PatelChief Medical Officer
- EMEmmanuelle Marie CharpentierCo-Founder & Scientific Advisory Board Member
- CCCraig C. MelloScientific Founder & Advisory Board Member
- MPMatthew PorteusScientific Founder & Advisory Board Member
- DGDaniel G. AndersonScientific Founder & Advisory Board Member
